Kinetix Medicine adds Neurolyser XR for incision-free pain care in Vancouver

Kinetix Medicine has bought the first Neurolyser XR system in the Vancouver metro area, with patient treatments set to begin Aug. 26, 2026. The move expands access in British Columbia to a non-invasive option for chronic lumbar facet joint pain using focused ultrasound guided by fluoroscopy.

Why it matters: - Kinetix Medicine’s purchase gives Vancouver-area patients access to a non-invasive treatment option for chronic lumbar facet joint pain. - The Neurolyser XR adds another incision-free alternative to conventional radiofrequency ablation. - The installation expands focused ultrasound pain therapy in British Columbia and across Western Canada.

What happened: - Kinetix Medicine bought the first Neurolyser XR system in the Vancouver metropolitan area. - The system installation is scheduled for August 2026. - The first patient treatments are set to begin Aug. 26, 2026. - FUSMobile Inc. announced the installation and the Vancouver expansion.

The details: - Kinetix Medicine was co-founded by Dr. Sanjiv (Sonny) Bhalla, Dr. Case Van Wyngaarden and Dr. Darren Gray. - The Neurolyser XR uses high-intensity focused ultrasound, or HIFU, guided by fluoroscopy. - The system is designed to provide a completely non-invasive treatment option for chronic lumbar facet joint pain. - Dr. Bhalla said the treatment is evidence-based and approved by Health Canada and the FDA. - Kinetix Medicine works across diagnostic imaging, interventional radiology, physiatry, regenerative medicine and advanced pain management. - FUSMobile said Neurolyser XR installations now span more than 10 countries, including Canada and the United States. - FUSMobile develops HIFU technologies for chronic pain treatment without incisions or needles. - FUSMobile said Neurolyser XR combines focused ultrasound with fluoroscopic guidance for precise, non-invasive treatment of chronic musculoskeletal pain. - Kinetix Medicine has served patients for 10 years and treats patients from Vancouver, Western Canada and the United States. - Patients can find more information at Kinetix Medicine or call Andrea at 604-416-0630. - Media contacts for FUSMobile include Bruce Taylor, NRP, North America Sales Manager, at 610-Neuro-XR and Info@FUSMobile.com. - FUSMobile also lists its website and social media links on LinkedIn and YouTube.

Between the lines: - The Vancouver purchase signals a broader push to place Neurolyser XR systems with specialty pain clinics that can market advanced, minimally invasive care. - The announcement frames focused ultrasound as the next generation of image-guided pain therapy, positioning the technology against more established procedures. - Kinetix Medicine’s focus on evidence-based, minimally invasive treatments suggests the clinic is using the purchase to deepen its specialization in interventional pain care.

What's next: - Kinetix Medicine will complete installation in August 2026. - The clinic will begin treating its first patients on Aug. 26, 2026. - FUSMobile is likely to continue expanding Neurolyser XR partnerships in North America and beyond as part of its commercial rollout. - Media are welcome to attend the launch around the first patient treatments.